PMID: 2043048Jan 1, 1991Paper

Cyclophosphamide metabolism in the primary immune organs of the chick: assays of drug activation, P450 expression, and aldehyde dehydrogenase

Archives of Toxicology
R R MisraS E Bloom

Abstract

Several diagnostic catalytic assays were used to determine whether organ-specific metabolic activation or detoxification of cyclophosphamide (CP) contributes to the selective toxicity of CP directed towards differentiating B cells as compared to T cells in the developing chicken. An assay for the alkylation of 4-[p-nitrobenzyl] pyridine (NBP) was used to assess comparative levels of CP activation products generated from microsomal preparations from liver, bursa of Fabricius (B cells), and thymus (T cells) of day-old chicks. Three catalytic assays were used to characterize and compare cytochrome P450-associated enzyme activities in neonatal hepatic and lymphoid tissues. Aldrin epoxidase (AE) was used to detect phenobarbital (PB)-inducible P450 activity. Ethoxyresorufin-O-deethylase (EROD) and aryl hydrocarbon hydroxylase (AHH) were used for the evaluation of polycyclic aromatic hydrocarbon (PAH)-inducible P450 activities in control and PB- or 3,3',4,4'-tetrachlorobiphenyl (TCB)-induced animals. Using the NBP assay, basal and PB-induced CP activation were observed using chick liver microsomes. However, no evidence of CP activation from immune organ microsomes was observed in control, PB-, or TCB-induced chicks. Basal and PB-induc...Continue Reading

References

Jan 1, 1978·Analytical Biochemistry·C S Yang, L P Kicha
Jan 1, 1978·Biochemical Pharmacology·R A DeitrichJ Schmuck
Sep 1, 1986·Journal of Biochemical Toxicology·M S DenisonC F Wilkinson
Jan 1, 1988·Pharmacology & Therapeutics·N E Sladek
Dec 1, 1987·Cancer Genetics and Cytogenetics·L M SargentL F Meisner
Jan 1, 1985·Environmental Mutagenesis·R R DietertS E Bloom
Aug 1, 1985·Carcinogenesis·C BolognesiL Santi
Sep 1, 1974·Cellular Immunology·J Eskola, P Toivanen
Jan 1, 1982·Immunological Reviews·J L Turk, D Parker
Jun 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·J W HamiltonS E Bloom
Jun 1, 1981·Environmental Health Perspectives·D W Nebert
Nov 1, 1980·Biochemical Pharmacology·B E Domeyer, N E Sladek

Citations

Oct 26, 1995·Biochemical Pharmacology·D R GermolecM I Luster
Jan 1, 1992·International Journal of Immunopharmacology·K A GolemboskiR R Dietert
May 1, 1992·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·A C CochónR Wainstok de Calmanovici

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.